Stock listing

Thalia Therapeutics Plc

Selected listing: THAT.GB · AQUIS · GBX · GB

Thalia Therapeutics Plc (AQUIS:THAT.GB), Health Technology. Latest release Sep 30, 2026: Interim Results.

THAT.GB:AQUISGBXGBUpdated October 3, 2026

Ticker: AQUIS:THAT.GB
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: AQUIS
Currency: GBX

About Thalia Therapeutics Plc

The company focuses on developing innovative therapeutic solutions. Thalia Therapeutics aims to address unmet medical needs through its research and development efforts.

Latest news from Thalia Therapeutics Plc

Interim Results

September 30, 2026

New Patent Granted for miRisten in China

September 29, 2026

RNA gene-silencing cardiovascular program advances

September 25, 2026

Business Update and Notice of Results

September 15, 2026

Grant of Director Share Options

July 23, 2026

All Thalia Therapeutics Plc news →

Events

Replays

THALIA THERAPEUTICS PLC (THAT) — Interim results for the six months ended 30 June 2026
Wed, Sep 30, 2026 · 09:00 AM ET
Watch
THALIA THERAPEUTICS PLC (THAT) — Investor Presentation
Wed, Jun 24, 2026 · 09:00 AM ET
Watch
THALIA THERAPEUTICS PLC (THAT) — Interim results for the six months ended 30 June 2025
Thu, Sep 25, 2025 · 09:00 AM ET
Watch

Research Thalia Therapeutics Plc

Thalia Therapeutics Plc company profile

View the public company page for Thalia Therapeutics Plc on 6ix.

Thalia Therapeutics Plc news

Read company news and market updates connected to Thalia Therapeutics Plc.

Thalia Therapeutics Plc investor events

Find investor webinars, events, and replay context for Thalia Therapeutics Plc.